Novel Drug Delivery Systems
fundamentals and applications
$530.02
- Hardcover
496 pages
- Release Date
11 September 2024
Summary
Novel Drug Delivery Systems: A Comprehensive Guide
This book serves as a unique resource on the field of novel drug delivery systems (NDDSs), catering to both academic audiences (researchers, teachers, students) and industry professionals (pharmaceutical policymakers, managers, R&D, regulatory, business development, and marketing) involved in NDDSs.
The evolving nature of diseases and the emergence of new health complications have driven a significant sh…
Book Details
| ISBN-13: | 9781119852285 |
|---|---|
| ISBN-10: | 1119852285 |
| Author: | Mehrdad Hamidi, Mahsa Sayed Tabatabaei |
| Publisher: | John Wiley & Sons Inc |
| Imprint: | Wiley-Scrivener |
| Format: | Hardcover |
| Number of Pages: | 496 |
| Release Date: | 11 September 2024 |
| Weight: | 907g |
You Can Find This Book In
About The Author
Mehrdad Hamidi
Mehrdad Hamidi, PhD, obtained his doctorate from the Tehran University of Medical Sciences, Tehran, Iran in 1999. His main research field is novel delivery systems focusing on BBB transport of CNS-active drugs. He has published many articles in international journals, two books, multiple book chapters, three contributions to an encyclopedia, and 5 US patents. Concurrently, he is a member of the Iranian Academy of Medical Sciences, the Founding Chairman and Founding CEO of two knowledge-based entrepreneurial pharmaceutical companies, and the Chair of the Iranian Association of Pharmaceutical Scientists.
Mahsa Sayed Tabatabaei, PhD, obtained her doctorate at Shahid Behesthi University of Medical Sciences, Iran in 2022. She is currently a pharmaceutical R&D Project Manager at Hida Pharma in Tehran engaged in different nanotechnology-based drug delivery projects, mainly drug self-delivery systems, peptide and protein delivery, self-assembled nanostructures, and novel cosmeceuticals.
Returns
This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.